{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:25:51Z","timestamp":1784640351530,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00432-023-05475-7","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T17:01:45Z","timestamp":1699376505000},"page":"17771-17780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models"],"prefix":"10.1007","volume":"149","author":[{"given":"Hanaa Ali","family":"EL-Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-203X","authenticated-orcid":false,"given":"Maha","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5052-9150","authenticated-orcid":false,"given":"Regan","family":"Bucciol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Awad","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmed Mohammed Abdallah","family":"EL-Agdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Tera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa H.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam Rashad","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek El-Sayed","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"5475_CR1","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/S0049-3848(16)30138-4","volume":"140","author":"S Adri\u00e1n","year":"2016","unstructured":"Adri\u00e1n S et al (2016) PO-05-Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting. Thromb Res 140:S178","journal-title":"Thromb Res"},{"issue":"3","key":"5475_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MBC.0b013e32831bc2de","volume":"20","author":"G Arpaia","year":"2009","unstructured":"Arpaia G et al (2009) D-dimer before chemotherapy might predict venous thromboembolism. Blood Coag Fibrinol 20(3):170\u2013175","journal-title":"Blood Coag Fibrinol"},{"issue":"5","key":"5475_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22072","volume":"31","author":"H Ates","year":"2017","unstructured":"Ates H et al (2017) Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal 31(5):e22072","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"5475_CR4","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1373\/clinchem.2006.085068","volume":"53","author":"C Ay","year":"2007","unstructured":"Ay C et al (2007) High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 53(7):1235\u20131243","journal-title":"Clin Chem"},{"issue":"7","key":"5475_CR5","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","volume":"112","author":"C Ay","year":"2008","unstructured":"Ay C et al (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112(7):2703\u20132708","journal-title":"Blood"},{"issue":"6","key":"5475_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.clml.2014.05.003","volume":"14","author":"R Colombo","year":"2014","unstructured":"Colombo R, Gallipoli P, Castelli R (2014) Thrombosis and hemostatic abnormalities in hematological malignancies. Clin Lymphoma Myeloma Leuk 14(6):441\u2013450","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"5475_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.thromres.2010.05.012","volume":"126","author":"GC Connolly","year":"2010","unstructured":"Connolly GC et al (2010) Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res 126(2):113\u2013118","journal-title":"Thromb Res"},{"issue":"2","key":"5475_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1538-7836.2007.02328.x","volume":"5","author":"M Di Nisio","year":"2007","unstructured":"Di Nisio M et al (2007) Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 5(2):296\u2013304","journal-title":"J Thromb Haemost"},{"issue":"2","key":"5475_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","volume":"22","author":"E Donnellan","year":"2017","unstructured":"Donnellan E, Khorana AA (2017) Cancer and venous thromboembolic disease: a review. Oncologist 22(2):199\u2013207","journal-title":"Oncologist"},{"issue":"2","key":"5475_CR10","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.21608\/ejhm.2022.270820","volume":"89","author":"HA El-sayed","year":"2022","unstructured":"El-sayed HA et al (2022) Validity of modified Vienna-CATS score for prediction of venous thromboembolism in Egyptian cancer cases. Egyptian J Hospital Med 89(2):6831\u20136838","journal-title":"Egyptian J Hospital Med"},{"key":"5475_CR11","doi-asserted-by":"publisher","DOI":"10.1182\/hem.V8.4.1244","author":"A Falanga","year":"2011","unstructured":"Falanga A (2011) The cancer-thrombosis connection. Hematologist. https:\/\/doi.org\/10.1182\/hem.V8.4.1244","journal-title":"Hematologist"},{"issue":"5","key":"5475_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ijc.29076","volume":"136","author":"P Ferroni","year":"2015","unstructured":"Ferroni P et al (2015) Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio. Int J Cancer 136(5):1234\u20131240","journal-title":"Int J Cancer"},{"key":"5475_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8781379","volume":"2017","author":"P Ferroni","year":"2017","unstructured":"Ferroni P et al (2017) Validation of a machine learning approach for venous thromboembolism risk prediction in oncology. Dis Markers 2017:1","journal-title":"Dis Markers"},{"issue":"12","key":"5475_CR14","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmauric","year":"2019","unstructured":"Fitzmauric C et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749\u20131768","journal-title":"JAMA Oncol"},{"issue":"12","key":"5475_CR15","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/cncr.21496","volume":"104","author":"AA Khorana","year":"2005","unstructured":"Khorana AA et al (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104(12):2822\u20132829","journal-title":"Cancer"},{"issue":"10","key":"5475_CR16","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA et al (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902\u20134907","journal-title":"Blood"},{"issue":"2","key":"5475_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdj068","volume":"17","author":"K Kr\u00f6ger","year":"2006","unstructured":"Kr\u00f6ger K et al (2006) Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 17(2):297\u2013303","journal-title":"Ann Oncol"},{"issue":"1","key":"5475_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12959-019-0202-z","volume":"17","author":"A-S Mirza","year":"2019","unstructured":"Mirza A-S et al (2019) Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience. Thromb J 17(1):1\u20136","journal-title":"Thromb J"},{"issue":"11","key":"5475_CR19","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/s41409-020-0921-6","volume":"55","author":"J Montoro","year":"2020","unstructured":"Montoro J et al (2020) Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors. Bone Marrow Transplant 55(11):2147\u20132159","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"5475_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","volume":"104","author":"FI Mulder","year":"2019","unstructured":"Mulder FI et al (2019) The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica 104(6):1277","journal-title":"Haematologica"},{"issue":"3","key":"5475_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/jth.13594","volume":"15","author":"S Noble","year":"2017","unstructured":"Noble S et al (2017) Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment. J Thromb Haemost 15(3):590\u2013591","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5475_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/ATVBAHA.108.182188","volume":"29","author":"I Pabinger","year":"2009","unstructured":"Pabinger I, Ay C (2009) Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol 29(3):332\u2013336","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5475_CR23","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-2453","author":"L Peng","year":"2022","unstructured":"Peng L et al (2022) High level of neutrophil to lymphocyte ratio increases the risk of deep venous thrombosis in intensive care unit patients after oral cancer surgery: a retrospective study. Ann Transl Med. https:\/\/doi.org\/10.21037\/atm-22-2453","journal-title":"Ann Transl Med"},{"issue":"8","key":"5475_CR24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","volume":"3","author":"J Polgar","year":"2005","unstructured":"Polgar J, Matuskova J, Wagner D (2005) The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3(8):1590\u20131596","journal-title":"J Thromb Haemost"},{"key":"5475_CR25","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S0049-3848(07)70137-8","volume":"120","author":"FR Rickles","year":"2007","unstructured":"Rickles FR et al (2007) Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? Thromb Res 120:S99\u2013S106","journal-title":"Thromb Res"},{"issue":"1","key":"5475_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/cancers11010095","volume":"11","author":"S Riondino","year":"2019","unstructured":"Riondino S et al (2019) Predicting VTE in cancer patients: candidate biomarkers and risk assessment models. Cancer 11(1):95","journal-title":"Cancer"},{"issue":"04","key":"5475_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-0037-1613051","volume":"87","author":"S Sallah","year":"2002","unstructured":"Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87(04):575\u2013579","journal-title":"Thromb Haemost"},{"issue":"1","key":"5475_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","volume":"8","author":"R Simanek","year":"2010","unstructured":"Simanek R et al (2010) High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 8(1):114\u2013120","journal-title":"J Thromb Haemost"},{"issue":"9","key":"5475_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2015.0133","volume":"13","author":"MB Streiff","year":"2015","unstructured":"Streiff MB et al (2015) Cancer-associated venous thromboembolic disease, version1. 2015. J Natl Compr Cancer Netw 13(9):1079\u20131095","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"5475_CR30","first-page":"1712","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF et al (2013) Epidemiology of cancer-associated venous thrombosis Blood. J Am Soc Hematol 122(10):1712\u20131723","journal-title":"J Am Soc Hematol"},{"issue":"05","key":"5475_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1160\/TH08-05-0339","volume":"100","author":"J Trujillo-Santos","year":"2008","unstructured":"Trujillo-Santos J et al (2008) Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Thromb Haemost 100(05):905\u2013911","journal-title":"Thromb Haemost"},{"issue":"10","key":"5475_CR32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.ejca.2010.03.007","volume":"46","author":"N Uaprasert","year":"2010","unstructured":"Uaprasert N et al (2010) Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis. Eur J Cancer 46(10):1790\u20131799","journal-title":"Eur J Cancer"},{"issue":"7","key":"5475_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","volume":"149","author":"M Verhovsek","year":"2008","unstructured":"Verhovsek M et al (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 149(7):481\u2013490","journal-title":"Ann Intern Med"},{"issue":"3","key":"5475_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/1759-7714.12178","volume":"6","author":"G Wu","year":"2015","unstructured":"Wu G et al (2015) Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Thoracic Cancer 6(3):275\u2013287","journal-title":"Thoracic Cancer"},{"key":"5475_CR35","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/S0049-3848(10)70024-4","volume":"125","author":"T Wun","year":"2010","unstructured":"Wun T, White RH (2010) Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thromb Res 125:S96\u2013S102","journal-title":"Thromb Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T15:03:24Z","timestamp":1702739004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":35,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5475"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05475-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research adhered to the Code of Ethics of the World Medical Association (Declaration of Helsinki) for studies involving human subjects. The project was approved by Mansoura University Board of ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the patients involved in the study provided the written consent for participation and publication of scientific data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}